1,961
Views
23
CrossRef citations to date
0
Altmetric
Reviews

Short-chain fatty acids-producing probiotics: A novel source of psychobiotics

, ORCID Icon & ORCID Icon

References

  • Adams, J. B., L. J. Johansen, L. D. Powell, D. Quig, and R. A. Rubin. 2011. Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity. BMC Gastroenterology 11 (1):22. doi: 10.1186/1471-230X-11-22.
  • Agahi, A., G. A. Hamidi, R. Daneshvar, M. Hamdieh, M. Soheili, A. Alinaghipour, S. M. E. Taba, and M. Salami. 2018. Does severity of Alzheimer’s disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Frontiers in Neurology 9:662. doi: 10.3389/fneur.2018.00662.
  • Aizawa, E., H. Tsuji, T. Asahara, T. Takahashi, T. Teraishi, S. Yoshida, M. Ota, N. Koga, K. Hattori, and H. Kunugi. 2016. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. Journal of Affective Disorders 202:254–7. doi: 10.1016/j.jad.2016.05.038.
  • Akbari, E., Z. Asemi, R. Daneshvar Kakhaki, F. Bahmani, E. Kouchaki, O. R. Tamtaji, G. A. Hamidi, and M. Salami. 2016. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: A randomized, double-blind and controlled trial. Frontiers in Aging Neuroscience 8:256. doi: 10.3389/fnagi.2016.00256.
  • Akhoundzadeh, K., A. Vakili, M. Shadnoush, and J. &Sadeghzadeh. 2018. Effects of the oral ingestion of probiotics on brain damage in a transient model of focal cerebral ischemia in mice. Iranian Journal of Medical Sciences 43 (1):32–40.
  • Akkasheh, G., Z. Kashani-Poor, M. Tajabadi-Ebrahimi, P. Jafari, H. Akbari, M. Taghizadeh, M. R. Memarzadeh, Z. Asemi, and A. Esmaillzadeh. 2016. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition 32 (3):315–20. doi: 10.1016/j.nut.2015.09.003.
  • Alipour Nosrani, E., O. R. Tamtaji, Z. Alibolandi, P. Sarkar, M. Ghazanfari, A. Azami Tameh, M. Taghizadeh, Z. Banikazemi, R. Hadavi, and M. Naderi Taheri. 2021. Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study. Journal of Immunoassay and Immunochemistry 42 (2):106–20. doi: 10.1080/15321819.2020.1833917.
  • Allen, A. P., W. Hutch, Y. E. Borre, P. J. Kennedy, A. Temko, G. Boylan, E. Murphy, J. F. Cryan, T. G. Dinan, and G. Clarke. 2016. Bifidobacterium longum 1714 as a translational psychobiotic: Modulation of stress, electrophysiology and neurocognition in healthy volunteers. Translational Psychiatry 6 (11):e939. doi: 10.1038/tp.2016.191.
  • Arpaia, N., C. Campbell, X. Fan, S. Dikiy, J. Van Der Veeken, P. Deroos, H. Liu, J. R. Cross, K. Pfeffer, P. J. Coffer, et al. 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504 (7480):451–5. doi: 10.1038/nature12726.
  • Bambury, A., K. Sandhu, J. F. Cryan, and T. G. Dinan. 2018. Finding the needle in the haystack: Systematic identification of psychobiotics. British Journal of Pharmacology. 175 (24):4430–8. doi: 10.1111/bph.14127.
  • Barichella, M., C. Pacchetti, C. Bolliri, E. Cassani, L. Iorio, C. Pusani, G. Pinelli, G. Privitera, I. Cesari, S. A. Faierman, et al. 2016. Probiotics and prebiotic fiber for constipation associated with Parkinson disease. Neurology 87 (12):1274–80. doi: 10.1212/WNL.0000000000003127.
  • Batista, A. F., V. Bodart-Santos, F. G. De Felice, and S. T. Ferreira. 2019. Neuroprotective actions of glucagon-like peptide-1 (GLP-1) analogues in Alzheimer's and Parkinson's diseases. CNS Drugs 33 (3):209–23. doi: 10.1007/s40263-018-0593-6.
  • Bedarf, J. R., F. Hildebrand, L. P. Coelho, S. Sunagawa, M. Bahram, F. Goeser, P. Bork, and U. Wüllner. 2017. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients. Genome Medicine 9 (1):39. doi: 10.1186/s13073-017-0428-y.
  • Ben Menachem-Zidon, O., Y. Ben Menahem, T. Ben Hur, and R. Yirmiya. 2015. Intra-hippocampal transplantation of neural precursor cells with transgenic over-expression of IL-1 receptor antagonist rescues memory and neurogenesis impairments in an Alzheimer's disease model. Neuropsychopharmacology 40 (2):524. doi: 10.1038/npp.2014.264.
  • Bloom, G. S. 2014. Amyloid-β and tau: The trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurology 71 (4):505–8. doi: 10.1001/jamaneurol.2013.5847.
  • Bonfili, L., V. Cecarini, S. Berardi, S. Scarpona, J. S. Suchodolski, C. Nasuti, D. Fiorini, M. C. Boarelli, G. Rossi, and A. M. Eleuteri. 2017. Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. Scientific Reports 7 (1):2426. doi: 10.1038/s41598-017-02587-2.
  • Bonfili, L., V. Cecarini, M. Cuccioloni, M. Angeletti, S. Berardi, S. Scarpona, G. Rossi, and A. M. Eleuteri. 2018. SLAB51 probiotic formulation activates SIRT1 pathway promoting antioxidant and neuroprotective effects in an AD mouse model. Molecular Neurobiology 55 (10):7987–8000. doi: 10.1007/s12035-018-0973-4.
  • Bonfili, L., V. Cecarini, O. Gogoi, S. Berardi, S. Scarpona, M. Angeletti, G. Rossi, and A. M. Eleuteri. 2020. Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer's disease. Neurobiology of Aging 87:35–43. doi: 10.1016/j.neurobiolaging.2019.11.004.
  • Borre, Y. E., G. W. O’keeffe, G. Clarke, C. Stanton, T. G. Dinan, and J. F. Cryan. 2014. Microbiota and neurodevelopmental windows: Implications for brain disorders. Trends in Molecular Medicine 20 (9):509–18. doi: 10.1016/j.molmed.2014.05.002.
  • Borzabadi, S., S. Oryan, A. Eidi, E. Aghadavod, R. Daneshvar Kakhaki, O. R. Tamtaji, M. Taghizadeh, and Z. Asemi. 2018. The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson’s disease: A randomized, double-blind, placebocontrolled trial. Archives of Iranian Medicine 21 (7):289–95.
  • Bravo, J. A., P. Forsythe, M. V. Chew, E. Escaravage, H. M. Savignac, T. G. Dinan, J. Bienenstock, and J. F. Cryan. 2011. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America 108 (38):16050–5. doi: 10.1073/pnas.1102999108.
  • Buffington, S. A., S. W. Dooling, M. Sgritta, C. Noecker, O. D. Murillo, D. F. Felice, P. J. Turnbaugh, and M. Costa-Mattioli. 2021. Dissecting the contribution of host genetics and the microbiome in complex behaviors. Cell 184 (7):1740–56. doi: 10.1016/j.cell.2021.02.009.
  • Burokas, A., S. Arboleya, R. D. Moloney, V. L. Peterson, K. Murphy, G. Clarke, C. Stanton, T. G. Dinan, and J. F. Cryan. 2017. Targeting the microbiota-gut-brain axis: Prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biological Psychiatry 82 (7):472–87. doi: 10.1016/j.biopsych.2016.12.031.
  • Cai, Z., M. D. Hussain, and L. J. Yan. 2014. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease. International Journal of Neuroscience 124 (5):307–21. doi: 10.3109/00207454.2013.833510.
  • Cao, X., K. Liu, J. Liu, Y. W. Liu, L. Xu, H. Wang, Y. Zhu, P. Wang, Z. Li, J. Wen, et al. 2021. Dysbiotic gut microbiota and dysregulation of cytokine profile in children and teens with autism spectrum disorder. Frontiers in Neuroscience 15:635925. doi: 10.3389/fnins.2021.635925.
  • Cassir, N., S. Benamar, and B. La Scola. 2016. Clostridium butyricum: From beneficial to a new emerging pathogen. Clinical Microbiology and Infection 22 (1):37–45. doi: 10.1016/j.cmi.2015.10.014.
  • Chaste, P., and M. Leboyer. 2012. Autism risk factors: Genes, environment, and gene-environment interactions. Dialogues in Clinical Neuroscience 14 (3):281–92. doi: 10.31887/DCNS.2012.14.3/pchaste.
  • Chen, D., D. Jin, S. Huang, J. Wu, M. Xu, T. Liu, W. Dong, X. Liu, S. Wang, W. Zhong, et al. 2020. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Letters 469:456–67. doi: 10.1016/j.canlet.2019.11.019.
  • Chen, F., W. Wang, H. Ding, Q. Yang, Q. Dong, and M. Cui. 2016. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia. Journal of Neuroinflammation 13 (1):204. doi: 10.1186/s12974-016-0661-0.
  • Chen, H., X. Ma, Y. Liu, L. Ma, Z. Chen, X. Lin, L. Si, X. Ma, and X. Chen. 2019. Gut microbiota interventions with Clostridium butyricum and norfloxacin modulate immune response in experimental autoimmune encephalomyelitis mice. Frontiers in Immunology 10:1662. doi: 10.3389/fimmu.2019.01662.
  • Chen, R., Y. Xu, P. Wu, H. Zhou, Y. Lasanajak, Y. Fang, L. Tang, L. Ye, X. Li, Z. Cai, et al. 2019. Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota. Pharmacological Research 148:104403. doi: 10.1016/j.phrs.2019.104403.
  • Chen, S., S. J. Yu, Y. Li, D. Lecca, E. Glotfelty, H. K. Kim, H.-I. Choi, B. J. Hoffer, N. H. Greig, D. S. Kim, et al. 2018. Post-treatment with PT302, a long-acting exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease. Scientific Reports 8 (1):10722. doi: 10.1038/s41598-018-28449-z.
  • Chen, Y. H., F. Xue, S. F. Yu, X. S. Li, L. Liu, Y. Y. Jia, W.-j. Yan, Q.-r. Tan, H.-n. Wang, and Z. W. Peng. 2021. Gut microbiota dysbiosis in depressed women: The association of symptom severity and microbiota function. Journal of Affective Disorders 282:391–400. doi: 10.1016/j.jad.2020.12.143.
  • Chen, Z. F., L. Y. Ai, J. L. Wang, L. L. Ren, Y. N. Yu, J. Xu, H.-Y. Chen, J. Yu, M. Li, W.-X. Qin, et al. 2015. Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis. Future Microbiology 10 (9):1433–45. doi: 10.2217/fmb.15.66.
  • Cheng, L. H., Y. W. Liu, C. C. Wu, S. Wang, and Y. C. Tsai. 2019. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. Journal of Food and Drug Analysis 27 (3):632–48. doi: 10.1016/j.jfda.2019.01.002.
  • Choi, S. I., J. H. Son, N. Kim, Y. S. Kim, R. H. Nam, J. H. Park, C.-H. Song, J. E. Yu, D. H. Lee, K. Yoon, et al. 2021. Changes in cecal microbiota and short-chain fatty acid during lifespan of the rat. Journal of Neurogastroenterology and Motility 27 (1):134–46. doi: 10.5056/jnm20148.
  • Chong, H. X., N. A. A. Yusoff, Y.-Y. Hor, L.-C. Lew, M. H. Jaafar, S.-B. Choi, M. S. B. Yusoff, N. Wahid, M. F. I. L. Abdullah, N. Zakaria, et al. 2019. Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: A randomised, double-blind, placebo-controlled study. Beneficial Microbes 10 (4):355–73. doi: 10.3920/BM2018.0135.
  • Chung, H.-Y., J. Wickel, F. M. Brunkhorst, and C. Geis. 2020. Sepsis-associated encephalopathy: From delirium to dementia? Journal of Clinical Medicine 9 (3):703. doi: 10.3390/jcm9030703.
  • Cignarella, F., C. Cantoni, L. Ghezzi, A. Salter, Y. Dorsett, L. Chen, D. Phillips, G. M. Weinstock, L. Fontana, A. H. Cross, et al. 2018. Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota. Cell Metabolism 27 (6):1222–35.e6. doi: 10.1016/j.cmet.2018.05.006.
  • Cornejo-Pareja, I., A. Muñoz-Garach, M. Clemente-Postigo, and F. J. Tinahones. 2019. Importance of gut microbiota in obesity. European Journal of Clinical Nutrition 72 (1):26–37. doi: 10.1038/s41430-018-0306-8.
  • Cousens, L. S., D. Gallwitz, and B. M. Alberts. 1979. Different accessibilities in chromatin to histone acetylase. Journal of Biological Chemistry 254 (5):1716–23. doi: 10.1016/S0021-9258(17)37831-6.
  • Cryan, J. F., K. J. O’riordan, C. S. M. Cowan, K. V. Sandhu, T. F. S. Bastiaanssen, M. Boehme, M. G. Codagnone, S. Cussotto, C. Fulling, A. V. Golubeva, et al. 2019. The microbiota-gut-brain axis. Physiological Reviews 99 (4):1877–2013. doi: 10.1152/physrev.00018.2018.
  • Cuche, G., S. Blat, and C. H. Malbert. 2001. Desensitization of ileal vagal receptors by short-chain fatty acids in pigs. The American Journal of Physiology-Gastrointestinal and Liver Physiology 280 (5):G1013–21. doi: 10.1152/ajpgi.2001.280.5.G1013.
  • Dalile, B., L. Van Oudenhove, B. Vervliet, and K. Verbeke. 2019. The role of short-chain fatty acids in microbiota-gut-brain communication. Nature Reviews Gastroenterology & Hepatology. 16 (8):461–78. doi: 10.1038/s41575-019-0157-3.
  • Daneman, R., and A. Prat. 2015. The blood-brain barrier. Cold Spring Harbor Perspectives in Biology 7 (1):a020412. doi: 10.1101/cshperspect.a020412.
  • De Vos, W. M., and E. A. De Vos. 2012. Role of the intestinal microbiome in health and disease: From correlation to causation. Nutrition Reviews 70 (Suppl 1):S45–S56. doi: 10.1111/j.1753-4887.2012.00505.x.
  • Den, H., X. Dong, M. Chen, and Z. Zou. 2020. Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment—A meta-analysis of randomized controlled trials. Aging 12 (4):4010–39. doi: 10.18632/aging.102810.
  • Dinan, T. G., C. Stanton, and J. F. Cryan. 2013. Psychobiotics: A novel class of psychotropic. Biological Psychiatry 74 (10):720–6. doi: 10.1016/j.biopsych.2013.05.001.
  • Dorsey, E. R., and B. R. Bloem. 2018. The Parkinson pandemic—A call to action. JAMA Neurology 75 (1):9–10. doi: 10.1001/jamaneurol.2017.3299.
  • Du, L., Z. Mei, Y. Huang, W. Tao, K. Wang, W. Huang, H. Zhou, and Z. Feng. 2020. Protection of the Geum japonicum Thunb. var. chinense extracts against oxygen-glucose deprivation and re-oxygenation induced astrocytes injury via BDNF/PI3K/Akt/CREB pathway. Biomedicine & Pharmacotherapy 127:110123. doi: 10.1016/j.biopha.2020.110123.
  • Dupont, H. L., Z.-D. Jiang, A. W. Dupont, and N. S. &Utay. 2020. The intestinal microbiome in human health and disease. Transactions of the American Clinical and Climatological Association 131:178–97.
  • Emir, G. K., Y. Nal, N. Yılmaz, K. Tosun, and G. Kutlu. 2019. The association of low levels of nesfatin-1 and glucagon-like peptide-1 with oxidative stress in Parkinson’s disease. Neurological Sciences 40 (12):2529–35. doi: 10.1007/s10072-019-03975-4.
  • Fang, X., P. Tian, X. Zhao, C. Jiang, and T. Chen. 2019. Neuroprotective effects of an engineered commensal bacterium in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine Parkinson disease mouse model via producing glucagon-like peptide-1. Journal of Neurochemistry 150 (4):441–52. doi: 10.1111/jnc.14694.
  • Ferraris, L., M.-J. Butel, and J. Aires. 2010. Antimicrobial susceptibility and resistance determinants of Clostridium butyricum isolates from preterm infants. International Journal of Antimicrobial Agents 36 (5):420–3. doi: 10.1016/j.ijantimicag.2010.07.005.
  • Flowers, S. A., N. T. Baxter, K. M. Ward, A. Z. Kraal, M. G. Mcinnis, T. M. Schmidt, and V. L. Ellingrod. 2019. Effects of atypical antipsychotic treatment and resistant starch supplementation on gut microbiome composition in a cohort of patients with bipolar disorder or schizophrenia. Pharmacotherapy 39 (2):161–70. doi: 10.1002/phar.2214.
  • Forsythe, P., and W. A. Kunze. 2013. Voices from within: Gut microbes and the CNS. Cellular and Molecular Life Sciences 70 (1):55–69. doi: 10.1007/s00018-012-1028-z.
  • Frost, G., M. L. Sleeth, M. Sahuri-Arisoylu, B. Lizarbe, S. Cerdan, L. Brody, J. Anastasovska, S. Ghourab, M. Hankir, S. Zhang, et al. 2014. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature Communications 5:3611. doi: 10.1038/ncomms4611.
  • Fukuda, S., S. Nakagawa, R. Tatsumi, Y. Morofuji, T. Takeshita, K. Hayashi, K. Tanaka, T. Matsuo, and M. Niwa. 2016. Glucagon-like peptide-1 strengthens the barrier integrity in primary cultures of rat brain endothelial cells under basal and hyperglycemia conditions. Journal of Molecular Neuroscience 59 (2):211–9. doi: 10.1007/s12031-015-0696-1.
  • Fung, T. C., C. A. Olson, and E. Y. Hsiao. 2017. Interactions between the microbiota, immune and nervous systems in health and disease. Nature Neuroscience 20 (2):145–55. doi: 10.1038/nn.4476.
  • Furusawa, Y., Y. Obata, S. Fukuda, T. A. Endo, G. Nakato, D. Takahashi, Y. Nakanishi, C. Uetake, K. Kato, T. Kato, et al. 2013. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (7480):446–50. doi: 10.1038/nature12721.
  • GBD 2015 Neurological Disorders Collaborator Group. 2017. Global, regional, and national burden of neurological disorders during 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurology 16 (11):877–97. doi: 10.1016/S1474-4422(17)30299-5.
  • Gerhardt, S., and M. H. Mohajeri. 2018. Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases. Nutrients 10 (6):708. doi: 10.3390/nu10060708.
  • Gheorghe, R. O., Deftu, A. Filippi, A. Grosu, A. Bica-Popi, M. Chiritoiu, C. Munteanu, L. Silvestro, and V. Ristoiu. 2020. Silencing the cytoskeleton protein Iba1 (Ionized calcium binding adapter protein 1) interferes with BV2 microglia functioning. Cellular and Molecular Neurobiology 40 (6):1011–27. doi: 10.1007/s10571-020-00790-w.
  • Goetz, L. H., and N. J. Schork. 2018. Personalized medicine: Motivation, challenges, and progress. Fertility and Sterility 109 (6):952–63. doi: 10.1016/j.fertnstert.2018.05.006.
  • Gordon, N., and G. Goelman. 2016. Understanding alterations in serotonin connectivity in a rat model of depression within the monoamine-deficiency and the hippocampal-neurogenesis frameworks. Behavioural Brain Research 296:141–8. doi: 10.1016/j.bbr.2015.09.013.
  • Goswami, C., Y. Iwasaki, and T. Yada. 2018. Short-chain fatty acids suppress food intake by activating vagal afferent neurons. Journal of Nutritional Biochemistry 57:130–5. doi: 10.1016/j.jnutbio.2018.03.009.
  • Govindarajan, N., R. C. Agis-Balboa, J. Walter, F. Sananbenesi, and A. Fischer. 2011. Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. Journal of Alzheimer's Disease 26 (1):187–97. doi: 10.3233/JAD-2011-110080.
  • Grenham, S., G. Clarke, J. F. Cryan, and T. G. Dinan. 2011. Brain-gut-microbe communication in health and disease. Frontiers in Physiology 2:94. doi: 10.3389/fphys.2011.00094.
  • Grimaldi, R., G. R. Gibson, J. Vulevic, N. Giallourou, J. L. Castro-Mejía, L. H. Hansen, E. L. Gibson, D. S. Nielsen, and Costabile. A. 2018. A prebiotic intervention study in children with autism spectrum disorders (ASDs). Microbiome 6 (1):133. doi: 10.1186/s40168-018-0523-3.
  • Gu, F., Y. Wu, Y. Liu, M. Dou, Y. Jiang, and H. Liang. H. 2020. Lactobacillus casei improves depression-like behavior in chronic unpredictable mild stress-induced rats by the BDNF-TrkB signal pathway and the intestinal microbiota. Food & Function 11 (7):6148–57. doi: 10.1039/d0fo00373e.
  • Høverstad, T., and T. Midtvedt. 1986. Short-chain fatty acids in germfree mice and rats. Journal of Nutrition 116 (9):1772–6. doi: 10.1093/jn/116.9.1772.
  • Haghighat, N., S. Rajabi, and M. Mohammadshahi. M. 2019. Effect of synbiotic and probiotic supplementation on serum brain-derived neurotrophic factor level, depression and anxiety symptoms in hemodialysis patients: A randomized, double-blinded, clinical trial. Nutritional Neuroscience. doi: 10.1080/1028415X.2019.1646975. (in press)
  • Hayashi, A., T. Sato, N. Kamada, Y. Mikami, K. Matsuoka, T. Hisamatsu, T. Hibi, A. Roers, H. Yagita, T. Ohteki, et al. 2013. A Single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host & Microbe. 13 (6):711–22. doi: 10.1016/j.chom.2013.05.013.
  • He, B., T. K. Hoang, X. Tian, C. M. Taylor, E. Blanchard, M. Luo, M. B. Bhattacharjee, J. Freeborn, S. Park, J. Couturier, et al. 2019. Lactobacillus reuteri reduces the severity of experimental autoimmune encephalomyelitis in mice by modulating gut microbiota. Frontiers in Immunology 10:385. doi: 10.3389/fimmu.2019.00385.
  • Holst, J. J., R. Burcelin, and E. Nathanson. 2011. Neuroprotective properties of GLP-1: Theoretical and practical applications. Current Medical Research and Opinion 27 (3):547–58. doi: 10.1185/03007995.2010.549466.
  • Hwang, Y.-H., S. Park, J.-W. Paik, S.-W. Chae, D.-H. Kim, D.-G. Jeong, E. Ha, M. Kim, G. Hong, S.-H. Park, et al. 2019. Efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: A 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial. Nutrients 11 (2):305. doi: 10.3390/nu11020305.
  • Hyman, S. L., S. E. Levy, S. M. Myers, and Council on Children with Disabilities, Section on Developmental and Behavioral Pediatrics. 2020. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Pediatrics 145 (1):e20193447. doi: 10.1542/peds.2019-3447.
  • Ishii, T., H. Furuoka, M. Kaya, and T. Kuhara. 2021. Oral administration of probiotic bifidobacterium breve improves facilitation of hippocampal memory extinction via restoration of aberrant higher induction of neuropsin in an MPTP-induced mouse model of Parkinson's disease. Biomedicines 9 (2):167. doi: 10.3390/biomedicines9020167.
  • Jandhyala, S. M., R. Talukdar, C. Subramanyam, H. Vuyyuru, M. Sasikala, and D. Nageshwar Reddy. 2015. Role of the normal gut microbiota. World Journal of Gastroenterology 21 (29):8787–803. doi: 10.3748/wjg.v21.i29.8787.
  • Janelidze, S., D. Mattei, Å Westrin, L. Träskman-Bendz, and L. Brundin. 2011. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain, Behavior, and Immunity 25 (2):335–9. doi: 10.1016/j.bbi.2010.10.010.
  • Janik, R., L. A. M. Thomason, A. M. Stanisz, P. Forsythe, J. Bienenstock, and G. J. Stanisz. 2016. Magnetic resonance spectroscopy reveals oral Lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate. NeuroImage 125:988–95. doi: 10.1016/j.neuroimage.2015.11.018.
  • Jeremias, I. C., V. J. Victorino, H. V. Barbeiro, S. A. Kubo, C. M. Prado, T. M. Lima, and F. G. Soriano. 2016. The role of acetylcholine in the inflammatory response in animals surviving sepsis induced by cecal ligation and puncture. Molecular Neurobiology 53 (10):6635–43. doi: 10.1007/s12035-015-9538-y.
  • Jiang, H., Z. Ling, Y. Zhang, H. Mao, Z. Ma, Y. Yin, W. Wang, W. Tang, Z. Tan, J. Shi, et al. 2015. Altered fecal microbiota composition in patients with major depressive disorder. Brain, Behavior, and Immunity 48:186–94. doi: 10.1016/j.bbi.2015.03.016.
  • Jin, M., J. Li, F. Liu, N. Lyu, K. Wang, L. Wang, S. Liang, H. Tao, B. Zhu, and R. Alkasir. 2019. Analysis of the gut microflora in patients with Parkinson's disease. Frontiers in Neuroscience 13:1184. doi: 10.3389/fnins.2019.01184.
  • Kalia, L. V., and A. E. Lang. 2015. Parkinson's disease. The Lancet 386 (9996):896–912. doi: 10.1016/S0140-6736(14)61393-3.
  • Kaur, H., S. Golovko, M. Y. Golovko, S. Singh, D. C. Darland, and C. K. Combs. 2020. Effects of probiotic supplementation on short chain fatty acids in the AppNL-G-F mouse model of Alzheimer's disease. Journal of Alzheimer's Disease 76 (3):1083–102. doi: 10.3233/jad-200436.
  • Kazemi, A., A. A. Noorbala, K. Azam, M. H. Eskandari, and K. Djafarian. 2019. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial. Clinical Nutrition 38 (2):522–8. doi: 10.1016/j.clnu.2018.04.010.
  • Kelly, J. R., A. P. Allen, A. Temko, W. Hutch, P. J. Kennedy, N. Farid, E. Murphy, G. Boylan, J. Bienenstock, J. F. Cryan, et al. 2017. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain, Behavior, and Immunity 61:50–9. doi: 10.1016/j.bbi.2016.11.018.
  • Keshavarzian, A., S. J. Green, P. A. Engen, R. M. Voigt, A. Naqib, C. B. Forsyth, E. Mutlu, and K. M. Shannon. 2015. Colonic bacterial composition in Parkinson's disease. Movement Disorders 30 (10):1351–60. doi: 10.1002/mds.26307.
  • Kim, C. H., J. Park, and M. Kim. 2014. Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Network 14 (6):277–88. doi: 10.4110/in.2014.14.6.277.
  • Kim, S. W., J. M. Hooker, N. Otto, K. Win, L. Muench, C. Shea, P. Carter, P. King, A. E. Reid, N. D. Volkow, et al. 2013. Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET. Nuclear Medicine and Biology 40 (7):912–8. doi: 10.1016/j.nucmedbio.2013.06.007.
  • Kobayashi, Y., T. Kinoshita, A. Matsumoto, K. Yoshino, I. Saito, and J. Z. Xiao. 2019. Bifidobacterium breve A1 supplementation improved cognitive decline in older adults with mild cognitive impairment: An open-label, single-arm study. The Journal of Prevention of Alzheimer's Disease 6 (1):1–75. doi: 10.14283/jpad.2018.32.
  • Kobayashi, Y., T. Kuhara, M. Oki, and J. Z. Xiao. 2019. Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: A randomised, double-blind, placebo-controlled trial. Benef Microbes 10 (5):511–20. doi: 10.3920/bm2018.0170.
  • Kobayashi, Y., H. Sugahara, K. Shimada, E. Mitsuyama, T. Kuhara, A. Yasuoka, T. Kondo, K. Abe, and J. Z. Xiao. 2017. Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease. Scientific Reports 7 (1):13510. doi: 10.1038/s41598-017-13368-2.
  • Kodak, T., and S. Bergmann. 2020. Autism spectrum disorder: Characteristics, associated behaviors, and early intervention. Pediatric Clinics of North America 67 (3):525–35. doi: 10.1016/j.pcl.2020.02.007.
  • Kong, Q., B. Wang, P. Tian, X. Li, J. Zhao, H. Zhang, W. Chen, and G. Wang. 2021. Daily intake of Lactobacillus alleviates autistic-like behaviors by ameliorating the 5-hydroxytryptamine metabolic disorder in VPA-treated rats during weaning and sexual maturation. Food & Function 12 (6):2591–604. doi: 10.1039/d0fo02375b.
  • Kouchaki, E., O. R. Tamtaji, M. Salami, F. Bahmani, R. Daneshvar Kakhaki, E. Akbari, M. Tajabadi-Ebrahimi, P. Jafari, and Z. Asemi. 2017. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition 36 (5):1245–9. doi: 10.1016/j.clnu.2016.08.015.
  • Krüger, J. F., E. Hillesheim, A. Pereira, C. Q. Camargo, and E. I. Rabito. E. I. 2021. Probiotics for dementia: A systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews 79 (2):160–70. doi: 10.1093/nutrit/nuaa037.
  • Larraufie, P., C. Martin-Gallausiaux, N. Lapaque, J. Dore, F. M. Gribble, F. Reimann, and H. M. Blottiere. 2018. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Scientific Reports 8 (1):74. doi: 10.1038/s41598-017-18259-0.
  • Lee, H. J., K. E. Lee, J. K. Kim, and D. H. Kim. 2019. Suppression of gut dysbiosis by Bifidobacterium longum alleviates cognitive decline in 5XFAD transgenic and aged mice. Scientific Reports 9 (1):11814. doi: 10.1038/s41598-019-48342-7.
  • Lee, J., J. D’aigle, L. Atadja, V. Quaicoe, P. Honarpisheh, B. P. Ganesh, A. Hassan, J. Graf, J. Petrosino, N. Putluri, et al. 2020. Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice. Circulation Research 127 (4):453–65. doi: 10.1161/circresaha.119.316448.
  • Lew, L.-C., Y.-Y. Hor, N. A. A. Yusoff, S.-B. Choi, M. S. B. Yusoff, N. S. Roslan, A. Ahmad, J. A. M. Mohammad, M. F. I. L. Abdullah, N. Zakaria, et al. 2019. Probiotic Lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults: A randomised, double-blind, placebo-controlled study. Clinical Nutrition 38 (5):2053–64. doi: 10.1016/j.clnu.2018.09.010.
  • Ley, R. E., P. J. Turnbaugh, S. Klein, and J. I. Gordon. 2006. Microbial ecology: Human gut microbes associated with obesity. Nature 444 (7122):1022–3. doi: 10.1038/4441022a.
  • Li, B., Y. He, J. Ma, P. Huang, J. Du, L. Cao, Y. Wang, Q. Xiao, H. Tang, and S. Chen. 2019. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota. Alzheimer's & Dementia 15 (10):1357–66. doi: 10.1016/j.jalz.2019.07.002.
  • Li, C., L. Cui, Y. Yang, J. Miao, X. Zhao, J. Zhang, G. Cui, and Y. Zhang. 2019. Gut microbiota differs between Parkinson's disease patients and healthy controls in Northeast China. Frontiers in Molecular Neuroscience 12:171. doi: 10.3389/fnmol.2019.00171.
  • Li, H., J. Sun, J. Du, F. Wang, R. Fang, C. Yu, J. Xiong, W. Chen, Z. Lu, and J. Liu. 2018. Clostridium butyricum exerts a neuroprotective effect in a mouse model of traumatic brain injury via the gut-brain axis. Neurogastroenterology & Motility 30 (5):e13260. doi: 10.1111/nmo.13260.
  • Li, H., J. Sun, F. Wang, G. Ding, W. Chen, R. Fang, Y. Yao, M. Pang, Z.-Q. Lu, and J. Liu. 2016. Sodium butyrate exerts neuroprotective effects by restoring the blood-brain barrier in traumatic brain injury mice. Brain Research 1642:70–8. doi: 10.1016/j.brainres.2016.03.031.
  • Liao, J.-F., Y.-F. Cheng, S.-T. You, W.-C. Kuo, C.-W. Huang, J.-J. Chiou, C.-C. Hsu, H.-M. Hsieh-Li, S. Wang, and Y.-C. Tsai. 2020. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson’s disease. Brain, Behavior, and Immunity 90:26–46. doi: 10.1016/j.bbi.2020.07.036.
  • Ling, Z., Y. Cheng, X. Yan, L. Shao, X. Liu, D. Zhou, L. Zhang, K. Yu, and L. Zhao. 2020. Alterations of the fecal microbiota in Chinese patients with multiple sclerosis. Frontiers in Immunology 11:590783. doi: 10.3389/fimmu.2020.590783.
  • Ling, Z., X. Liu, Y. Cheng, Y. Luo, L. Yuan, L. Li, and C. Xiang. 2015. Clostridium butyricum combined with Bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic-associated diarrhea. Biomed Research International 2015:582048. doi: 10.1155/2015/582048.
  • Ling, Z., M. Zhu, X. Yan, Y. Cheng, L. Shao, X. Liu, R. Jiang, and S. Wu. 2020. Structural and functional dysbiosis of fecal microbiota in Chinese patients with Alzheimer's sisease. Frontiers in Cell and Developmental Biology 8:634069. doi: 10.3389/fcell.2020.634069.
  • Liu, J., Y. Jin, H. Li, J. Yu, T. Gong, X. Gao, and J. Sun. 2020. Probiotics exert protective effect against sepsis-induced cognitive impairment by reversing gut microbiota abnormalities. Journal of Agricultural and Food Chemistry 68 (50):14874–83. doi: 10.1021/acs.jafc.0c06332.
  • Liu, J., H. Li, T. Gong, W. Chen, S. Mao, Y. Kong, J. Yu, and J. Sun. 2020. Anti-neuroinflammatory effect of short-chain fatty acid acetate against Alzheimer's disease via upregulating GPR41 and inhibiting ERK/JNK/NF-κB. Journal of Agricultural and Food Chemistry 68 (27):7152–61. doi: 10.1021/acs.jafc.0c02807.
  • Liu, J., J. Sun, F. Wang, X. Yu, Z. Ling, H. Li, H. Zhang, J. Jin, W. Chen, M. Pang, et al. 2015. Neuroprotective effects of Clostridium butyricum against vascular dementia in mice via metabolic butyrate. Biomed Research International 2015:412946. doi: 10.1155/2015/412946.
  • Liu, J., F. Wang, S. Liu, J. Du, X. Hu, J. Xiong, R. Fang, W. Chen, and J. Sun. 2017. Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1. Journal of the Neurological Sciences 381:176–81. doi: 10.1016/j.jns.2017.08.3235.
  • Liu, M., W. Xie, X. Wan, and T. Deng. 2020. Clostridium butyricum protects intestinal barrier function via upregulation of tight junction proteins and activation of the Akt/mTOR signaling pathway in a mouse model of dextran sodium sulfate-induced colitis. Experimental and Therapeutic Medicine 20 (5):10. doi: 10.3892/etm.2020.9138.
  • Liu, Y.-W., M. T. Liong, Y.-C. E. Chung, H.-Y. Huang, W.-S. Peng, Y.-F. Cheng, Y.-S. Lin, Y.-Y. Wu, and Y.-C. Tsai. 2019. Effects of Lactobacillus plantarum PS128 on children with autism spectrum disorder in Taiwan: A randomized, double-blind, placebo-controlled trial. Nutrients 11 (4):820. doi: 10.3390/nu11040820.
  • Liu, Z., L. Li, S. Ma, J. Ye, H. Zhang, Y. Li, A. T. Sair, J. Pan, X. Liu, X. Li, et al. 2020. High-dietary fiber intake alleviates antenatal obesity-induced postpartum depression: Roles of gut microbiota and microbial metabolite short-chain fatty acid involved. Journal of Agricultural and Food Chemistry 68 (47):13697–710. doi: 10.1021/acs.jafc.0c04290.
  • Long-Smith, C., K. J. O’riordan, G. Clarke, C. Stanton, T. G. Dinan, and J. F. Cryan. 2020. Microbiota-Gut-Brain Axis: New Therapeutic Opportunities. Annual Review of Pharmacology and Toxicology 60:477–502. doi: 10.1146/annurev-pharmtox-010919-023628.
  • Louis, P., G. L. Hold, and H. J. Flint. 2014. The gut microbiota, bacterial metabolites and colorectal cancer. Nature Reviews Microbiology 12 (10):661–72. doi: 10.1038/nrmicro3344.
  • Lynch, S. V., and O. Pedersen. 2016. The human intestinal microbiome in health and disease. New England Journal of Medicine 375 (24):2369–79. doi: 10.1056/NEJMra1600266.
  • Ma, T., H. Jin, L. Y. Kwok, Z. Sun, M. T. Liong, and H. Zhang. 2021. Probiotic consumption relieved human stress and anxiety symptoms possibly via modulating the neuroactive potential of the gut microbiota. Neurobiology of Stress 14:100294. doi: 10.1016/j.ynstr.2021.100294.
  • Ma, Y., T. Liu, J. Fu, S. Fu, C. Hu, B. Sun, X. Fan, and J. Zhu. 2019. Lactobacillus acidophilus exerts neuroprotective effects in mice with traumatic brain injury. The Journal of Nutrition 149 (9):1543–52. doi: 10.1093/jn/nxz105.
  • Mangiola, F., G. Ianiro, F. Franceschi, S. Fagiuoli, G. Gasbarrini, and A. Gasbarrini. 2016. Gut microbiota in autism and mood disorders. World Journal of Gastroenterology 22 (1):361–8. doi: 10.3748/wjg.v22.i1.361.
  • Manzanero, S., T. Santro, and T. V. Arumugam. 2013. Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury. Neurochemistry International 62 (5):712–8. doi: 10.1016/j.neuint.2012.11.009.
  • Martin, C. R., V. Osadchiy, A. Kalani, and E. A. Mayer. 2018. The brain-gut-microbiome axis. Cellular and Molecular Gastroenterology and Hepatology 6 (2):133–48. doi: 10.1016/j.jcmgh.2018.04.003.
  • Matt, S. M., J. M. Allen, M. A. Lawson, L. J. Mailing, J. A. Woods, and R. W. Johnson. 2018. Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice. Frontiers in Immunology 9:1832. doi: 10.3389/fimmu.2018.01832.
  • Mcintyre, R. S., M. J. Filteau, L. Martin, S. Patry, A. Carvalho, D. S. Cha, M. Barakat, and M. Miguelez. 2014. Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach. Journal of Affective Disorders 156:1–7. doi: 10.1016/j.jad.2013.10.043.
  • Messaoudi, M., R. Lalonde, N. Violle, H. Javelot, D. Desor, A. Nejdi, J.-F. Bisson, C. Rougeot, M. Pichelin, M. Cazaubiel, et al. 2011. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition 105 (5):755–64. doi: 10.1017/S0007114510004319.
  • Messaoudi, M., N. Violle, J.-F. Bisson, D. Desor, H. Javelot, and C. Rougeot. 2011. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes 2 (4):256–61. doi: 10.4161/gmic.2.4.16108.
  • Michels, M., A. S. Vieira, F. Vuolo, H. G. Zapelini, B. Mendonça, F. Mina, D. Dominguini, A. Steckert, P. F. Schuck, J. Quevedo, et al. 2015. The role of microglia activation in the development of sepsis-induced long-term cognitive impairment. Brain, Behavior, and Immunity 43:54–9. doi: 10.1016/j.bbi.2014.07.002.
  • Mitchell, R. W., N. H. On, M. R. Del Bigio, D. W. Miller, and G. M. Hatch. 2011. Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells. Journal of Neurochemistry 117 (4):735–46. doi: 10.1111/j.1471-4159.2011.07245.x.
  • Miyaoka, T., M. Kanayama, R. Wake, S. Hashioka, M. Hayashida, M. Nagahama, S. Okazaki, S. Yamashita, S. Miura, H. Miki, et al. 2018. Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder: A prospective open-label trial. Clinical Neuropharmacology 41 (5):151–5. doi: 10.1097/wnf.0000000000000299.
  • Molnár, L., B. Fülesdi, N. Németh, and C. Molnár. 2018. Sepsis-associated encephalopathy: A review of literature. Neurology India 66 (2):352–61. doi: 10.4103/0028-3886.227299.
  • Morais, L. H., H. L. T. Schreiber, and S. K. Mazmanian. 2021. The gut microbiota-brain axis in behaviour and brain disorders. Nature Reviews. Microbiology 19 (4):241–55. doi: 10.1038/s41579-020-00460-0.
  • Morrison, D. J., and T. Preston. 2016. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7 (3):189–200. doi: 10.1080/19490976.2015.1134082.
  • Muredda, L., M. A. Kępczyńska, M. S. Zaibi, S. Y. Alomar, and P. Trayhurn. 2018. IL-1β and TNFα inhibit GPR120 (FFAR4) and stimulate GPR84 (EX33) and GPR41 (FFAR3) fatty acid receptor expression in human adipocytes: Implications for the anti-inflammatory action of n-3 fatty acids . Archives of Physiology and Biochemistry 124 (2):97–108. doi: 10.1080/13813455.2017.1364774.
  • Musilova, S., N. Modrackova, P. Hermanova, T. Hudcovic, R. Svejstil, V. Rada, V. Tejnecky, and V. Bunesova. 2017. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice. Beneficial Microbes 8 (2):281–9. doi: 10.3920/bm2016.0138.
  • Nagashima, H., Y. Morio, S. Meshitsuka, K. Yamane, Y. Nanjo, and R. Teshima. 2010. High-resolution nuclear magnetic resonance spectroscopic study of metabolites in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy. European Spine Journal 19 (8):1363–8. doi: 10.1007/s00586-010-1453-3.
  • Nakka, V. P., A. Gusain, S. L. Mehta, and R. Raghubir. 2008. Molecular mechanisms of apoptosis in cerebral ischemia: Multiple neuroprotective opportunities. Molecular Neurobiology 37 (1):7–38. doi: 10.1007/s12035-007-8013-9.
  • Nimgampalle, M., and Y. Kuna. 2017. Anti-Alzheimer properties of probiotic, Lactobacillus plantarum MTCC 1325 in Alzheimer's disease induced albino rats. Journal of Clinical and Diagnostic Research 11 (8):KC01–5. doi: 10.7860/jcdr/2017/26106.10428.
  • O’Brien, J. T., and A. Thomas. 2017. Vascular dementia. Focus (American Psychiatric Publishing) 15 (1):1698–706. doi: 10.1016/S0140-6736(15)00463-8.
  • Oh, J., A. Vidal-Jordana, and X. Montalban. 2018. Multiple sclerosis: Clinical aspects. Current Opinion in Neurology 31 (6):752–9. doi: 10.1097/WCO.0000000000000622.
  • Okubo, R., M. Koga, N. Katsumata, T. Odamaki, S. Matsuyama, M. Oka, H. Narita, N. Hashimoto, I. Kusumi, J. Xiao, et al. 2019. Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study. Journal of Affective Disorders 245:377–85. doi: 10.1016/j.jad.2018.11.011.
  • Oliveros, E., M. Ramirez, E. Vazquez, A. Barranco, A. Gruart, J. M. Delgado-Garcia, R. Buck, R. Rueda, and M. J. Martin. 2016. Oral supplementation of 2'-fucosyllactose during lactation improves memory and learning in rats . The Journal of Nutritional Biochemistry 31:20–7. doi: 10.1016/j.jnutbio.2015.12.014.
  • Onori, M. P., and G. M. Van Woerden. 2021. Role of calcium/calmodulin-dependent kinase 2 in neurodevelopmental disorders. Brain Research Bulletin 171:209–20. doi: 10.1016/j.brainresbull.2021.03.014.
  • Onyszkiewicz, M., M. Gawrys-Kopczynska, P. Konopelski, M. Aleksandrowicz, A. Sawicka, E. Koźniewska, E. Samborowska, and M. Ufnal. 2019. Butyric acid, a gut bacteria metabolite, lowers arterial blood pressure via colon-vagus nerve signaling and GPR41/43 receptors. Pflugers Archiv 471 (11-12):1441–53. doi: 10.1007/s00424-019-02322-y.
  • Otte, C., S. M. Gold, B. W. Penninx, C. M. Pariante, A. Etkin, M. Fava, D. C. Mohr, and A. F. Schatzberg. 2016. Major depressive disorder. Nature Reviews. Disease Primers 2:16065. doi: 10.1038/nrdp.2016.65.
  • Owens, B. 2016. Multiple sclerosis. Nature 540 (7631):S1. doi: 10.1038/540S1a.
  • Ozaki, K., and S. Niida. 2019. [Genetic background for Alzheimer's disease: Knowledge accumulated from AD GWAS]. Brain Nerve 71 (10):1039–51. doi: 10.11477/mf.1416201403.
  • Pandey, G. N., H. S. Rizavi, R. Bhaumik, and X. Ren. 2019. Innate immunity in the postmortem brain of depressed and suicide subjects: Role of Toll-like receptors. Brain, Behavior, and Immunity 75:101–11. doi: 10.1016/j.bbi.2018.09.024.
  • Pandey, G. N., H. S. Rizavi, X. Ren, J. Fareed, D. A. Hoppensteadt, R. C. Roberts, R. R. Conley, and Y. Dwivedi. 2012. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. Journal of Psychiatric Research 46 (1):57–63. doi: 10.1016/j.jpsychires.2011.08.006.
  • Pascale, A., N. Marchesi, S. Govoni, A. Coppola, and C. Gazzaruso. 2019. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: New insights into old diseases. Current Opinion in Pharmacology 49:1–5. doi: 10.1016/j.coph.2019.03.011.
  • Persico, A. M., A. Ricciardello, and F. Cucinotta. 2019. Chapter 24—The psychopharmacology of autism spectrum disorder and Rett syndrome. In Handbook of clinical neurology, ed. V. I. Reus and D. Lindqvist, 391–414. Amsterdam: Elsevier.
  • Pinto-Sanchez, M. I., G. B. Hall, K. Ghajar, A. Nardelli, C. Bolino, J. T. Lau, F.-P. Martin, O. Cominetti, C. Welsh, A. Rieder, et al. 2017. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: A pilot study in patients with irritable bowel syndrome. Gastroenterology 153 (2):448–59.e8. doi: 10.1053/j.gastro.2017.05.003.
  • Psichas, A., M. L. Sleeth, K. G. Murphy, L. Brooks, G. A. Bewick, A. C. Hanyaloglu, M. A. Ghatei, S. R. Bloom, and G. Frost. 2015. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. International Journal of Obesity 39 (3):424–9. doi: 10.1038/ijo.2014.153.
  • Qi, D., C. Ouyang, Y. Wang, S. Zhang, X. Ma, Y. Song, HLi Yu, J. Tang, W. Fu, L. Sheng, et al. 2014. HO-1 attenuates hippocampal neurons injury via the activation of BDNF-TrkB-PI3K/Akt signaling pathway in stroke. Brain Research 1577:69–76. doi: 10.1016/j.brainres.2014.06.031.
  • Qian, Y., X. Yang, S. Xu, C. Wu, Y. Song, N. Qin, S.-D. Chen, and Q. Xiao. 2018. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease. Brain, Behavior, and Immunity 70:194–202. doi: 10.1016/j.bbi.2018.02.016.
  • Qu, L., J. Ren, L. Huang, B. Pang, X. Liu, X. Liu, B. Li, and Y. Shan. 2018. Antidiabetic effects of Lactobacillus casei fermented yogurt through reshaping gut microbiota structure in type 2 diabetic rats. Journal of Agricultural and Food Chemistry 66 (48):12696–705. doi: 10.1021/acs.jafc.8b04874.
  • Ransohoff, R. M., P. Kivisakk, and G. Kidd. 2003. Three or more routes for leukocyte migration into the central nervous system. Nature Reviews. Immunology 3 (7):569–81. doi: 10.1038/nri1130.
  • Reich, S. G., and J. M. Savitt. 2019. Parkinson's disease. The Medical Clinics of North America 103 (2):337–50. doi: 10.1016/j.mcna.2018.10.014.
  • Rodrigo, R., R. Fernández-Gajardo, R. Gutiérrez, J. M. Matamala, R. Carrasco, A. Miranda-Merchak, and W. Feuerhake. 2013. Oxidative stress and pathophysiology of ischemic stroke: Novel therapeutic opportunities. CNS & Neurological Disorders Drug Targets 12 (5):698–714. doi: 10.2174/1871527311312050015.
  • Romano, S., G. M. Savva, J. R. Bedarf, I. G. Charles, F. Hildebrand, and A. Narbad. 2021. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinson's Disease 7 (1):27 doi: 10.1038/s41531-021-00156-z.
  • Rudzki, L., L. Ostrowska, D. Pawlak, A. Małus, K. Pawlak, N. Waszkiewicz, and A. Szulc. 2019. Probiotic Lactobacillus plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study. Psychoneuroendocrinology 100:213–22. doi: 10.1016/j.psyneuen.2018.10.010.
  • Salcedo, I., D. Tweedie, Y. Li, and N. H. Greig. 2012. Neuroprotective and neurotrophic actions of glucagon-like peptide-1: An emerging opportunity to treat neurodegenerative and cerebrovascular disorders. British Journal of Pharmacology 166 (5):1586–99. doi: 10.1111/j.1476-5381.2012.01971.x.
  • Salehipour, Z., D. Haghmorad, M. Sankian, M. Rastin, R. Nosratabadi, M. M. Soltan Dallal, N. Tabasi, M. Khazaee, L. R. Nasiraii, and M. Mahmoudi. 2017. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 95:1535–48. doi: 10.1016/j.biopha.2017.08.117.
  • Sampson, T. R., J. W. Debelius, T. Thron, S. Janssen, G. G. Shastri, Z. E. Ilhan, C. Challis, C. E. Schretter, S. Rocha, V. Gradinaru, et al. 2016. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167 (6):1469–80.e2. doi: 10.1016/j.cell.2016.11.018.
  • Samuel, B. S., A. Shaito, T. Motoike, F. E. Rey, F. Backhed, J. K. Manchester, R. E. Hammer, S. C. Williams, J. Crowley, M. Yanagisawa, et al. 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the United States of America 105 (43):16767–72. doi: 10.1073/pnas.0808567105.
  • Sandler, R. H., S. M. Finegold, E. R. Bolte, C. P. Buchanan, A. P. Maxwell, M. L. Väisänen, M. N. Nelson, and H. M. Wexler. 2000. Short-term benefit from oral vancomycin treatment of regressive-onset autism. Journal of Child Neurology 15 (7):429–35. doi: 10.1177/088307380001500701.
  • Sarkar, A., S. M. Lehto, S. Harty, T. G. Dinan, J. F. Cryan, and P. W. J. Burnet. 2016. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends in Neurosciences 39 (11):763–81. doi: 10.1016/j.tins.2016.09.002.
  • Savignac, H. M., B. Kiely, T. G. Dinan, and J. F. Cryan. 2014. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterology and Motility 26 (11):1615–27. doi: 10.1111/nmo.12427.
  • Savignac, H. M., M. Tramullas, B. Kiely, T. G. Dinan, and J. F. Cryan. 2015. Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behavioural Brain Research 287:59–72. doi: 10.1016/j.bbr.2015.02.044.
  • Schönherr-Hellec, S., G. Klein, J. Delannoy, L. Ferraris, I. Friedel, J. C. Rozé, M. J. Butel, and J. Aires. 2017. Comparative phenotypic analysis of “Clostridium neonatale” and Clostridium butyricum isolates from neonates. Anaerobe 48:76–82. doi: 10.1016/j.anaerobe.2017.07.002.
  • Schmidt, K., P. J. Cowen, C. J. Harmer, G. Tzortzis, S. Errington, and P. W. Burnet. 2015. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology 232 (10):1793–801. doi: 10.1007/s00213-014-3810-0.
  • Schwarcz, R., J. P. Bruno, P. J. Muchowski, and H.-Q. Wu. 2012. Kynurenines in the mammalian brain: When physiology meets pathology. Nature Reviews. Neuroscience 13 (7):465–77. doi: 10.1038/nrn3257.
  • Sekirov, I., S. L. Russell, L. C. M. Antunes, and B. B. Finlay. 2010. Gut microbiota in health and disease. Physiological Reviews 90 (3):859–904. doi: 10.1152/physrev.00045.2009.
  • Sgritta, M., S. W. Dooling, S. A. Buffington, E. N. Momin, M. B. Francis, R. A. Britton, and M. Costa-Mattioli. 2019. Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder. Neuron 101 (2):246–59.e6. doi: 10.1016/j.neuron.2018.11.018.
  • Shahab, R. L., S. Brethauer, M. P. Davey, A. G. Smith, S. Vignolini, J. S. Luterbacher, and M. H. Studer. 2020. A heterogeneous microbial consortium producing short-chain fatty acids from lignocellulose. Science 369 (6507):eabb1214. doi: 10.1126/science.abb1214.
  • Shaaban, S. Y., Y. G. El Gendy, N. S. Mehanna, W. M. El-Senousy, H. S. A. El-Feki, K. Saad, and O. M. El-Asheer. 2018. The role of probiotics in children with autism spectrum disorder: A prospective, open-label study. Nutritional Neuroscience 21 (9):676–81. doi: 10.1080/1028415X.2017.1347746.
  • Shamsipour, S., G. Sharifi, and F. Taghian. 2021. An 8-week administration of Bifidobacterium bifidum and Lactobacillus plantarum combined with exercise training alleviates neurotoxicity of abeta and spatial learning via acetylcholine in Alzheimer rat model. Journal of Molecular Neuroscience. doi: 10.1007/s12031-021-01812-y. (in press)
  • Shetty, A. K., V. Mishra, M. Kodali, and B. Hattiangady. 2014. Blood brain barrier dysfunction and delayed neurological deficits in mild traumatic brain injury induced by blast shock waves. Frontiers in Cellular Neuroscience 8:232. doi: 10.3389/fncel.2014.00232.
  • Shlosberg, D., M. Benifla, D. Kaufer, and A. Friedman. 2010. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nature Reviews. Neurology 6 (7):393–403. doi: 10.1038/nrneurol.2010.74.
  • Shou, J., L. Zhou, S. Zhu, and X. Zhang. 2015. Diabetes is an independent risk factor for stroke recurrence in stroke patients: A meta-analysis. Journal of Stroke and Cerebrovascular Diseases 24 (9):1961–8. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.004.
  • Simpson, C. A., C. Diaz-Arteche, D. Eliby, O. S. Schwartz, J. G. Simmons, and C. S. M. Cowan. 2021. The gut microbiota in anxiety and depression—A systematic review. Clinical Psychology Review 83:101943. doi: 10.1016/j.cpr.2020.101943.
  • Singh, A., R. Kukreti, L. Saso, and S. Kukreti. 2019. Oxidative stress: A key modulator in neurodegenerative diseases. Molecules 24 (8):1583. doi: 10.3390/molecules24081583.
  • Singh, C. K., G. Chhabra, M. A. Ndiaye, L. M. Garcia-Peterson, N. J. Mack, and N. Ahmad. 2018. The role of sirtuins in antioxidant and redox signaling. Antioxidants & Redox Signaling 28 (8):643–61. doi: 10.1089/ars.2017.7290.
  • Smith, K. 2014. Mental health: A world of depression. Nature 515 (7526):181. doi: 10.1038/515180a.
  • Smith, P. M., M. R. Howitt, N. Panikov, M. Michaud, C. A. Gallini, M. Bohlooly-Y, J. N. Glickman, and W. S. Garrett. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science 341 (6145):569–73. doi: 10.1126/science.1241165.
  • Soliman, M. L., C. K. Combs, and T. A. Rosenberger. 2013. Modulation of inflammatory cytokines and mitogen-activated protein kinases by acetate in primary astrocytes. Journal of Neuroimmune Pharmacology 8 (1):287–300. doi: 10.1007/s11481-012-9426-4.
  • Soliman, M. L., K. L. Puig, C. K. Combs, and T. A. Rosenberger. 2012. Acetate reduces microglia inflammatory signaling in vitro. Journal of Neurochemistry 123 (4):555–67. doi: 10.1111/j.1471-4159.2012.07955.x.
  • Spichak, S., T. F. S. Bastiaanssen, K. Berding, K. Vlckova, G. Clarke, T. G. Dinan, and J. F. Cryan. 2021. Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease. Neuroscience and Biobehavioral Reviews 125:698–761. doi: 10.1016/j.neubiorev.2021.02.044.
  • Spychala, M. S., V. R. Venna, M. Jandzinski, S. J. Doran, D. J. Durgan, B. P. Ganesh, N. J. Ajami, N. Putluri, J. Graf, R. M. Bryan, et al. 2018. Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome. Annals of Neurology 84 (1):23–36. doi: 10.1002/ana.25250.
  • Srivastav, S., S. Neupane, S. Bhurtel, N. Katila, S. Maharjan, H. Choi, J. T. Hong, and D.-Y. Choi. 2019. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. The Journal of Nutritional Biochemistry 69:73–86. doi: 10.1016/j.jnutbio.2019.03.021.
  • Sudo, N., Y. Chida, Y. Aiba, J. Sonoda, N. Oyama, X.-N. Yu, C. Kubo, and Y. Koga. 2004. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. The Journal of Physiology 558 (Pt 1):263–75. doi: 10.1113/jphysiol.2004.063388.
  • Sun, J., H. Li, Y. Jin, J. Yu, S. Mao, K.-P. Su, Z. Ling, and J. Liu. 2021. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway. Brain, Behavior, and Immunity 91:703–15. doi: 10.1016/j.bbi.2020.10.014.
  • Sun, J., Z. Ling, F. Wang, W. Chen, H. Li, J. Jin, H. Zhang, M. Pang, J. Yu, and J. Liu. 2016. Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis. Neuroscience Letters 613:30–5. doi: 10.1016/j.neulet.2015.12.047.
  • Sun, J., F. Wang, G. Hong, M. Pang, H. Xu, H. Li, F. Tian, R. Fang, Y. Yao, and J. Liu. 2016. Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress. Neuroscience Letters 618:159–66. doi: 10.1016/j.neulet.2016.03.003.
  • Sun, J., F. Wang, X. Hu, C. Yang, H. Xu, Y. Yao, and J. Liu. 2018. Clostridium butyricum attenuates chronic unpredictable mild stress-induced depressive-like behavior in mice via the gut-brain axis. Journal of Agricultural and Food Chemistry 66 (31):8415–21. doi: 10.1021/acs.jafc.8b02462.
  • Sun, J., F. Wang, H. Li, H. Zhang, J. Jin, W. Chen, M. Pang, J. Yu, Y. He, J. Liu, et al. 2015. Neuroprotective effect of sodium butyrate against cerebral ischemia/reperfusion injury in mice. BioMed Research International 2015:395895. doi: 10.1155/2015/395895.
  • Sun, J., F. Wang, Z. Ling, X. Yu, W. Chen, H. Li, J. Jin, M. Pang, H. Zhang, J. Yu, et al. 2016. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. Brain Research 1642:180–8. doi: 10.1016/j.brainres.2016.03.042.
  • Sun, J., J. Xu, B. Yang, K. Chen, Y. Kong, N. Fang, T. Gong, F. Wang, Z. Ling, and J. Liu. 2020. Effect of Clostridium butyricum against microglia-mediated neuroinflammation in Alzheimer's disease via regulating gut microbiota and metabolites butyrate. Molecular Nutrition & Food Research 64 (2):e1900636. doi: 10.1002/mnfr.201900636.
  • Sun, M.-F., Y.-L. Zhu, Z.-L. Zhou, X.-B. Jia, Y.-D. Xu, Q. Yang, C. Cui, and Y.-Q. Shen. 2018. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway. Brain, Behavior, and Immunity 70:48–60. doi: 10.1016/j.bbi.2018.02.005.
  • Sweeney, M. D., Z. Zhao, A. Montagne, A. R. Nelson, and B. V. Zlokovic. 2019. Blood-brain barrier: From physiology to disease and back. Physiological Reviews 99 (1):21–78. doi: 10.1152/physrev.00050.2017.
  • Tabouy, L., D. Getselter, O. Ziv, M. Karpuj, T. Tabouy, I. Lukic, R. Maayouf, N. Werbner, H. Ben-Amram, M. Nuriel-Ohayon, et al. 2018. Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders. Brain, Behavior, and Immunity 73:310–9. doi: 10.1016/j.bbi.2018.05.015.
  • Taggart, A. K. P., J. Kero, X. Gan, T.-Q. Cai, K. Cheng, M. Ippolito, N. Ren, R. Kaplan, K. Wu, T.-J. Wu, et al. 2005. (D)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. The Journal of Biological Chemistry 280 (29):26649–52. doi: 10.1074/jbc.C500213200.
  • Takebayashi, N., H. Maeshima, H. Baba, Y. Nakano, E. Satomura, Y. Kita, Y. Namekawa, H. Nomoto, T. Suzuki, and H. Arai. 2012. Duration of last depressive episode may influence serum BDNF levels in remitted patients with major depression. Depression and Anxiety 29 (9):775–9. doi: 10.1002/da.21933.
  • Takeda, S. 2019. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors. Neuroscience Research 141:36–42. doi: 10.1016/j.neures.2018.08.005.
  • Takewaki, D., W. Suda, W. Sato, L. Takayasu, N. Kumar, K. Kimura, N. Kaga, T. Mizuno, S. Miyake, M. Hattori, et al. 2020. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 117 (36):22402–12. doi: 10.1073/pnas.2011703117.
  • Tamtaji, O. R., R. Heidari-Soureshjani, N. Mirhosseini, E. Kouchaki, F. Bahmani, E. Aghadavod, M. Tajabadi-Ebrahimi, and Z. Asemi. 2019. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial. Clinical Nutrition 38 (6):2569–75. doi: 10.1016/j.clnu.2018.11.034.
  • Tamtaji, O. R., M. Taghizadeh, R. Daneshvar Kakhaki, E. Kouchaki, F. Bahmani, S. Borzabadi, S. Oryan, A. Mafi, and Z. Asemi. 2019. Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition 38 (3):1031–5. doi: 10.1016/j.clnu.2018.05.018.
  • Tan, C., Q. Wu, H. Wang, X. Gao, R. Xu, Z. Cui, J. Zhu, X. Zeng, H. Zhou, Y. He, et al. 2021. Dysbiosis of gut microbiota and short-chain fatty acids in acute ischemic stroke and the subsequent risk for poor functional outcomes. Journal of Parenteral and Enteral Nutrition 45 (3):518–29. doi: 10.1002/jpen.1861.
  • Tang, C., and S. Offermanns. 2017. FFA2 and FFA3 in metabolic regulation. Handbook of Experimental Pharmacology 236:205–20. doi: 10.1007/164_2016_50.
  • Tang, X., R. Jaenisch, and M. Sur. 2021. The role of GABAergic signalling in neurodevelopmental disorders. Nature Reviews Neuroscience 22 (5):290–307. (in press) doi: 10.1038/s41583-021-00443-x.
  • Tankou, S. K., K. Regev, B. C. Healy, L. M. Cox, E. Tjon, P. Kivisakk, I. P. Vanande, S. Cook, R. Gandhi, B. Glanz, et al. 2018. Investigation of probiotics in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 24 (1):58–63. doi: 10.1177/1352458517737390.
  • Tankou, S. K., K. Regev, B. C. Healy, E. Tjon, L. Laghi, L. M. Cox, P. Kivisäkk, I. V. Pierre, L. Hrishikesh, R. Gandhi, et al. 2018. A probiotic modulates the microbiome and immunity in multiple sclerosis. Annals of Neurology 83 (6):1147–61. doi: 10.1002/ana.25244.
  • Thangaraju, M., G. A. Cresci, K. Liu, S. Ananth, J. P. Gnanaprakasam, D. D. Browning, J. D. Mellinger, S. B. Smith, G. J. Digby, N. A. Lambert, et al. 2009. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Research 69 (7):2826–32. doi: 10.1158/0008-5472.Can-08-4466.
  • Tian, P., K. J. O'Riordan, Y.-K. Lee, G. Wang, J. Zhao, H. Zhang, J. F. Cryan, and W. Chen. 2020. Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice. Neurobiology of Stress 12:100216. doi: 10.1016/j.ynstr.2020.100216.
  • Tian, P., G. Wang, J. Zhao, H. Zhang, and W. Chen. 2019. Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis. The Journal of Nutritional Biochemistry 66:43–51. doi: 10.1016/j.jnutbio.2019.01.007.
  • Tian, T., B. Xu, Y. Qin, L. Fan, J. Chen, P. Zheng, X. Gong, H. Wang, M. Bai, J. Pu, et al. 2019. Clostridium butyricum miyairi 588 has preventive effects on chronic social defeat stress-induced depressive-like behaviour and modulates microglial activation in mice. Biochemical and Biophysical Research Communications 516 (2):430–6. doi: 10.1016/j.bbrc.2019.06.053.
  • Tolhurst, G., H. Heffron, Y. S. Lam, H. E. Parker, A. M. Habib, E. Diakogiannaki, J. Cameron, J. Grosse, F. Reimann, and F. M. Gribble. 2012. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61 (2):364–71. doi: 10.2337/db11-1019.
  • Tundo, A., R. De Filippis, and L. Proietti. 2015. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience. World Journal of Psychiatry 5 (3):330–41. doi: 10.5498/wjp.v5.i3.330.
  • Turroni, S., P. Brigidi, A. Cavalli, and M. Candela. 2018. Microbiota-host transgenomic metabolism, bioactive molecules from the inside. Journal of Medicinal Chemistry 61 (1):47–61. doi: 10.1021/acs.jmedchem.7b00244.
  • Ullah, H., O. Tovchiga, M. Daglia, and H. Khan. 2021. Modulating gut microbiota: An emerging approach in the prevention and treatment of multiple sclerosis. Current Neuropharmacology. doi: 10.2174/1570159x19666210217084827. (in press)
  • Unger, M. M., J. Spiegel, K.-U. Dillmann, D. Grundmann, H. Philippeit, J. Bürmann, K. Faßbender, A. Schwiertz, and K.-H. Schäfer. 2016. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism & Related Disorders 32:66–72. doi: 10.1016/j.parkreldis.2016.08.019.
  • Valles-Colomer, M., G. Falony, Y. Darzi, E. F. Tigchelaar, J. Wang, R. Y. Tito, C. Schiweck, A. Kurilshikov, M. Joossens, C. Wijmenga, et al. 2019. The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology 4 (4):623–32. doi: 10.1038/s41564-018-0337-x.
  • van de Wouw, M., M. Boehme, J. M. Lyte, N. Wiley, C. Strain, O. O'Sullivan, G. Clarke, C. Stanton, T. G. Dinan, and J. F. Cryan. 2018. Short-chain fatty acids: Microbial metabolites that alleviate stress-induced brain-gut axis alterations. The Journal of Physiology 596 (20):4923–44. doi: 10.1113/jp276431.
  • Vella, M. A., M. L. Crandall, and M. B. Patel. 2017. Acute management of traumatic brain injury. The Surgical Clinics of North America 97 (5):1015–30. doi: 10.1016/j.suc.2017.06.003.
  • Venkat, P., M. Chopp, and J. Chen. 2015. Models and mechanisms of vascular dementia. Experimental Neurology 272:97–108. doi: 10.1016/j.expneurol.2015.05.006.
  • Vidot, H., E. Cvejic, L. J. Finegan, E. A. Shores, D. G. Bowen, S. I. Strasser, G. W. McCaughan, S. Carey, M. Allman-Farinelli, and N. A. Shackel. 2019. Supplementation with synbiotics and/or branched chain amino acids in hepatic encephalopathy: A pilot randomised placebo-controlled clinical study. Nutrients 11 (8):1810. doi: 10.3390/nu11081810.
  • Vuong, H. E., and E. Y. Hsiao. 2017. Emerging roles for the gut microbiome in autism spectrum disorder. Biological Psychiatry 81 (5):411–23. doi: 10.1016/j.biopsych.2016.08.024.
  • Wallace, C. J. K., and R. V. Milev. 2021. The efficacy, safety, and tolerability of probiotics on depression: Clinical results from an open-label pilot study. Frontiers in Psychiatry 12:618279. doi: 10.3389/fpsyt.2021.618279.
  • Wang, F., T. Xu, Y. Zhang, T. Zheng, Y. He, F. He, and Y. Jiang. 2020. Long-term combined administration of Bifidobacterium bifidum TMC3115 and Lactobacillus plantarum 45 alleviates spatial memory impairment and gut dysbiosis in APP/PS1 mice. FEMS Microbiology Letters 367 (7):fnaa048. doi: 10.1093/femsle/fnaa048.
  • Wang, H., C. Braun, E. F. Murphy, and P. Enck. 2019. Bifidobacterium longum 1714™ strain modulates brain activity of healthy volunteers during social stress. American Journal of Gastroenterology 114 (7):1152–62. doi: 10.14309/ajg.0000000000000203.
  • Wang, M. D., Y. Huang, G. P. Zhang, L. Mao, Y. P. Xia, Y. W. Mei, and B. Hu. 2012. Exendin-4 improved rat cortical neuron survival under oxygen/glucose deprivation through PKA pathway. Neuroscience 226:388–96. doi: 10.1016/j.neuroscience.2012.09.025.
  • Wang, T., W. Kuang, W. Chen, W. Xu, L. Zhang, Y. Li, C. Yan, Y. Du, M. Tang, Z. He, et al. 2020. A phase II randomized trial of sodium oligomannate in Alzheimer's dementia. Alzheimer's Research & Therapy 12 (1):110. doi: 10.1186/s13195-020-00678-3.
  • Wang, X., G. Sun, T. Feng, J. Zhang, X. Huang, T. Wang, Z. Xie, X. Chu, J. Yang, H. Wang, et al. 2019. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. Cell Research 29 (10):787–803. doi: 10.1038/s41422-019-0216-x.
  • Wang, Y., Y. Gu, K. Fang, K. Mao, J. Dou, H. Fan, C. Zhou, and H. Wang. 2018. Lactobacillus acidophilus and Clostridium butyricum ameliorate colitis in murine by strengthening the gut barrier function and decreasing inflammatory factors. Beneficial Microbes 9 (5):775–87. doi: 10.3920/bm2017.0035.
  • Wegh, C. A. M., S. Y. Geerlings, J. Knol, G. Roeselers, and C. Belzer. 2019. Postbiotics and their potential applications in early life nutrition and beyond. International Journal of Molecular Sciences 20 (19):4673. doi: 10.3390/ijms20194673.
  • Williams, N. T. 2010. Probiotics. American Journal of Health-System Pharmacy 67 (6):449–58. doi: 10.2146/ajhp090168.
  • Wolters, F. J., and M. A. Ikram. 2019. Epidemiology of vascular dementia. Arteriosclerosis, Thrombosis, and Vascular Biology 39 (8):1542–9. doi: 10.1161/atvbaha.119.311908.
  • Woo, T. D. H., K. Oka, M. Takahashi, F. Hojo, T. Osaki, T. Hanawa, S. Kurata, H. Yonezawa, and S. Kamiya. 2011. Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain. Journal of Medical Microbiology 60 (Pt 11):1617–25. doi: 10.1099/jmm.0.033423-0.
  • Xiao, S., P. Chan, T. Wang, Z. Hong, S. Wang, W. Kuang, J. He, X. Pan, Y. Zhou, Y. Ji, et al. 2021. A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia. Alzheimer's Research & Therapy 13 (1):62. doi: 10.1186/s13195-021-00795-7.
  • Xiao, S., S. Jiang, D. Qian, and J. Duan. 2020. Modulation of microbially derived short-chain fatty acids on intestinal homeostasis, metabolism, and neuropsychiatric disorder. Applied Microbiology and Biotechnology 104 (2):589–601. doi: 10.1007/s00253-019-10312-4.
  • Xiao, Y., X. Dai, K. Li, G. Gui, J. Liu, and H. Yang. 2017. Clostridium butyricum partially regulates the development of colitis-associated cancer through miR-200c. Cellular and Molecular Biology (Noisy-le-Grand, France) 63 (4):59–66. doi: 10.14715/cmb/2017.63.4.10.
  • Yang, C., Y. Fujita, Q. Ren, M. Ma, C. Dong, and K. Hashimoto. 2017. Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice. Scientific Reports 7:45942. doi: 10.1038/srep45942.
  • Yang, J., P. Zheng, Y. Li, J. Wu, X. Tan, J. Zhou, Z. Sun, X. Chen, G. Zhang, H. Zhang, et al. 2020. Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders. Science Advances 6 (49):eaba8555. doi: 10.1126/sciadv.aba8555.
  • Yang, Z., C. Weian, H. Susu, and W. Hanmin. 2016. Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms. European Journal of Pharmacology 771:145–51. doi: 10.1016/j.ejphar.2015.12.003.
  • Yao, Y., X. Cai, W. Fei, Y. Ye, M. Zhao, and C. Zheng. 2020. The role of short-chain fatty acids in immunity, inflammation and metabolism. Critical Reviews in Food Science and Nutrition, 1–12. doi: 10.1080/10408398.2020.1854675. (in press)
  • Yasueda, A., T. Mizushima, R. Nezu, R. Sumi, M. Tanaka, J. Nishimura, Y. Kai, M. Hirota, H. Osawa, K. Nakajima, et al. 2016. The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. Surgery Today 46 (8):939–49. doi: 10.1007/s00595-015-1261-9.
  • Yohn, C. N., M. M. Gergues, and B. A. Samuels. 2017. The role of 5-HT receptors in depression. Molecular Brain 10 (1):28. doi: 10.1186/s13041-017-0306-y.
  • Yunes, R. A., E. U. Poluektova, E. V. Vasileva, M. V. Odorskaya, M. V. Marsova, G. I. Kovalev, and V. N. Danilenko. 2020. A multi-strain potential probiotic formulation of GABA-producing Lactobacillus plantarum 90sk and Bifidobacterium adolescentis 150 with antidepressant effects. Probiotics and Antimicrobial Proteins 12 (3):973–979. doi: 10.1007/s12602-019-09601-1.
  • Zeng, X., X. Gao, Y. Peng, Q. Wu, J. Zhu, C. Tan, G. Xia, C. You, R. Xu, S. Pan, et al. 2019. Higher risk of stroke is correlated with increased opportunistic pathogen load and reduced levels of butyrate-producing bacteria in the gut. Frontiers in Cellular and Infection Microbiology 9:4. doi: 10.3389/fcimb.2019.00004.
  • Zhang, M., D. Zhao, G. Zhou, and C. Li. 2020. Dietary pattern, gut microbiota, and Alzheimer's disease. Journal of Agricultural and Food Chemistry 68 (46):12800–12809. doi: 10.1021/acs.jafc.9b08309.
  • Zhao, H., M. A. Yenari, D. Cheng, R. M. Sapolsky, and G. K. Steinberg. 2003. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. Journal of Neurochemistry 85 (4):1026–1036. doi: 10.1046/j.1471-4159.2003.01756.x.
  • Zhao, L., Y. Gao, S. Guo, X. Lu, S. Yu, Z. Z. Ge, H. D. Zhu, and Y. Li. 2020. Sepsis-associated encephalopathy: Insight into injury and pathogenesis. CNS & Neurological Disorders - Drug Targets. doi: 10.2174/1871527319999201117122158. (in press)
  • Zhao, Y. Z., M. Zhang, H. F. Liu, and J. P. Wang. 2015. Progesterone is neuroprotective by inhibiting cerebral edema after ischemia. Neural Regeneration Research 10 (7):1076–1081. doi: 10.4103/1673-5374.160097.
  • Zheng, D.-W., R.-Q. Li, J.-X. An, T.-Q. Xie, Z.-Y. Han, R. Xu, Y. Fang, and X.-Z. Zhang. 2020. Prebiotics-encapsulated probiotic spores regulate gut microbiota and suppress colon cancer. Advanced Materials 32 (45):e2004529. doi: 10.1002/adma.202004529.
  • Zheng, P., B. Zeng, C. Zhou, M. Liu, Z. Fang, X. Xu, L. Zeng, J. Chen, S. Fan, X. Du, et al. 2016. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Molecular Psychiatry 21 (6):786–796. doi: 10.1038/mp.2016.44.
  • Zhuang, Z.-Q L.-L., Shen, W.-W. Li, X. Fu, F. Zeng, L. Gui, Y. Lü, M. Cai, C. Zhu, Y.-L. Tan, et al. 2018. Gut microbiota is altered in patients with Alzheimer’s disease. Journal of Alzheimer's Disease 63 (4):1337–1346. doi: 10.3233/JAD-180176.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.